Summary
Variant CJD is one of the human prion diseases and has relatively uniform clinico-pathological characteristics, reflecting its presumed single cause and the uniform genotype of affected individuals. Typically, it presents with predominantly psychiatric features (often relatively non-specific ones suggesting depression) and any accompanying neurological features are often interpreted as part of a primarily psychiatric illness; variant CJD may be very difficult to diagnose in the early stages. Psychiatric features may remain as part of the overall picture even following the development of clear-cut neurological signs (after a median of around six months). The obviously neurological clinical picture is typically one of a rapidly progressive dementia with cerebellar ataxia, involuntary movements and painful sensory disturbances leading to death at a median of 14 months from onset. Definite diagnosis requires neuropathology but clinical diagnostic criteria have been developed allowing a very confident pre-mortem diagnosis in the majority of cases. These criteria depend on the exclusion of other diseases, the presence of a typical clinical picture and the results of certain supportive investigations, most notably the cerebral MRI and tonsil biopsy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Stanley B Prusiner (2004) An Introduction to Prion Biology and Diseases. In: Prion Biology and Diseases. Ed. Staley B Prusiner. Cold Spring Harbour Laboratory Press, New York, pp 1–87
Kovacs GG, Trabattoni G, Hainfellner JA, et al (2002) Mutations of the prion protein gene: phenotypic spectrum. J Neurol 249:1567–1582
Windl O, Dempster M, Estibeiro, et al (1996) Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet 98:259–264
Nurmi MH, Bishop M, Strain L, et al (2003) The normal population distribution of PRNP codon 129 polymorphism. Acta Neurol Scand 108:374–378
Bruce ME, Will RG, Ironside JW, et al (1997) Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature 389:498–501
Head MW, Bunn TJR, Bishop MT, et al (2004) Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991–2002. Ann Neurol 55:851–859
Knight R, Brazier M, Collins SJ (2004) Human prion diseases: cause, clinical and diagnostic aspects. In: Rabenau HF, Cinatl J, Doerr HW, editors. Prions. A challenge for science, medicine and the public health system. Basel: Karger pp 72–97
Parchi P, Giese A, Capellari S, et al (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224–233
NJ Andrews (2004) Incidence of variant Creutzfeldt-Jakob disease onsets and deaths in the UK. January 1994–September 2004. www.cjd.ed.ac.uk
Llewelyn CA, Hewitt PA, Knight RSG, et al (2004) Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363:417–421
Peden AH, Head MW, Ritchie DL, et al (2004) Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364:527–529
Spencer MD, Knight RSG, Will RG (2002) First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case note review of early psychiatric and neurological features. BMJ 324:1479–1482
Macleod MA, Stewart G, Zeidler M, et al (2002) Sensory features of variant Creutzfeldt-Jakob disease. J Neurol 249:706–711
Kapur N, Abbott P, Lowman A, Will RG. (2003) The neuropsychological profile associated with variant Creutzfeldt-Jakob disease. Brain 126:2693–2702
Green AJE, Knight RSG, Ironside JW (2003) Cerebrospinal fluid Tau protein as a diagnostic test for variant Creutzfeldt-Jakob disease. In: International Conference on Transmissible Spongiform Encephalopathies Book of Abstracts, 45.2003
AJE Green, EJ Thompson, GE Stewart et al (2001) Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 70:744–748
Collie DA, Summers DM, Sellar RJ, et al (2003) Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. Am J Neuroradiol 24:1560–1569
Hilton DA, Ghani AC, Conyers L, et al (2004) Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathology 203:733–739.
Will RG, Zeidler M, Stewart GE et al (2000) Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol 47:575–582
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Tokyo
About this paper
Cite this paper
Knight, R. (2005). Clinical Aspects of Variant CJD. In: Kitamoto, T. (eds) Prions. Springer, Tokyo. https://doi.org/10.1007/4-431-29402-3_2
Download citation
DOI: https://doi.org/10.1007/4-431-29402-3_2
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-25539-0
Online ISBN: 978-4-431-29402-3
eBook Packages: MedicineMedicine (R0)